About KAID
KAID is a Healthcare company based in United States founded in 2019 by Kevin Agatstein, and was acquired by PurpleLab in September 2025. AI and SaaS-based software for healthcare care coordination is developed. It operates in the Healthcare and Technology sectors. KAID has raised $8.09 million across 4 funding rounds from investors including PurpleLab, Activate Venture Partners and Martinson Ventures. Its chief executive, as recorded, is Kevin Agatstein. KAID offers products and services including Whole Chart Analysisâ„¢ and NLITEâ„¢. Its focus areas include Enterprise Infrastructure, Cognitive Computing, Applications and Healthcare and Lifesciences. Its competitors include R1 RCM, AKASA and XSOLIS; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2019 in the United States, KAID operates in the healthcare technology sector. A digital platform powered by AI is provided to support care management and coordination for organizations. Automated tools are included for managing EMR data, record-keeping, documentation, and compliance tracking. Features encompass patient chart summaries, population data analysis, and care planning. Operations focus on enhancing staff involvement in patient care processes.
- Headquarters United States
- Founders Kevin Agatstein
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website kaidhealth.com
- Social LinkedIn
- Acquired by PurpleLab (Sep 2025)
Products & Services of KAID
KAID offers a comprehensive portfolio of products and services, including Whole Chart Analysis™ and NLITE™.
Analyzes full patient data for accurate medical coding.
Extracts insights from unstructured medical notes for billing.
Funding Insights of KAID
KAID has successfully raised a total of $8.09M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.68 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.09M
- Total Rounds 4
- Last Round Series A — $1.68M
- First Round $560,000
(Mar 2020)
- Investors Count 5
All 4 funding rounds of KAID with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $1.68M | Series A | – | – | |
| May 2022 | $4.25M | Series A | – | Activate Venture Partners, Martinson Ventures | |
| Nov 2021 | $1.6M | Seed | – | – | – |
| Mar 2020 | $560,000 | Seed | – | – | – |
6 investors in total: 4 institutional and 2 angel.
Investors in KAID
KAID has secured backing from 6 investors, including venture fund and angel investors. Prominent investors backing the company include PurpleLab, Activate Venture Partners and Martinson Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital is provided by Activate Venture Partners. | activatevp.com | New York, United States | ||
Venture capital and private equity investments are provided by Martinson Ventures. | martinsonventures.com | |||
US-focused private equity and venture capital investments are managed. | bostonmillenniapartners.com | Boston, United States | ||
BH Brandon Hull | unknown_9912e141f5a0433eb | |||
HL Howard Landis | unknown_7d1b664b501e47a8b | |||
Healthcare analytics solutions for healthcare stakeholders | 2016 | purplelab.com | Furlong, United States |
Investor details for KAID
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of KAID
1 people are tracked at KAID (1 in leadership).
| Name | Role | Group |
|---|---|---|
Kevin Agatstein | Founder & CEO | Leadership |
Complete people profiles for KAID
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of KAID
4 dated milestones of KAID across 6 years, from founding to its latest funding, stage changes and deals.
- Founded KAID is founded.
- Funding First funding round of $560K.
- Funding Latest funding round, Series A, of $1.7M.
- Exit Acquired by PurpleLab.
Competitors of KAID
KAID has 3 listed competitors in our database, 2 of them funded. They include R1 RCM, AKASA and XSOLIS.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| r1rcm.com | 2003 | Chicago, United States | 16,445 | End-to-end revenue cycle management is provided for healthcare organizations. | ||
| akasa.com | 2018 | San Francisco, United States | $80M | 46 | Revenue cycle automation platforms are provided for healthcare reimbursement. | |
| xsolis.com | 2013 | Nashville, United States | $75M | 166 | AI-based platform for physicians and payers to analyze denial management |
Detailed competitors of KAID
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of KAID
The website of KAID (kaidhealth.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 49.3% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as KAID (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kaid
Complete news archive for KAID
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KAID
KAID was founded in 2019 and raised its 1st funding round 1 year after it was founded.
KAID is headquartered in United States.
Kevin Agatstein is the CEO of KAID, as recorded in our data. They have also founded this company.
KAID is a funded company, having raised a total of $8.09M across 4 funding rounds to date. The company's 1st funding round was a Seed of $560K, raised on Mar 2020.
Founded in 2019 in the United States, KAID operates in the healthcare technology sector. A digital platform powered by AI is provided to support care management and coordination for organizations. Automated tools are included for managing EMR data, record-keeping, documentation, and compliance tracking. Features encompass patient chart summaries, population data analysis, and care planning. Operations focus on enhancing staff involvement in patient care processes.
KAID offers Whole Chart Analysisâ„¢ and NLITEâ„¢.
KAID has 6 investors. Key investors include PurpleLab, Activate Venture Partners, Martinson Ventures, Boston Millennia Partners, and Brandon Hull.
Yes. KAID was acquired by PurpleLab in September 2025.

